{# max-image-preview:large is what makes an article eligible for the big-image card in Google Discover — without it Google may only show a thumbnail. #} {# ── Google Preferred Sources ──────────────────────────────────────────── Readers who mark us as a preferred source get our fresh articles prioritised in Top Stories, Discover and Google News. Only domain- and subdomain-level sites are eligible — blog.alfafinder.com qualifies, a /news/ subdirectory would not. #}

Wanbury — Latest News

Every announcement Wanbury has filed with the exchanges that we have reported, newest first. Each story links the original filing.

NSE: WANBURY BSE: 524212 Pharmaceuticals & Biotechnology 2 stories

Price

₹262.05

Market Cap

₹916.31

Revenue TTM

₹652.67

P/E (TTM)

16.4×

Sector 45.68×

Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.

Product Launched · 2
Product Launched

Wanbury Limited Secures EDQM Approval for Rivaroxaban API and Key USFDA Clearances

Wanbury Limited receives EDQM approval for Rivaroxaban API and USFDA DMF clearances for Paroxetine HCI and Metformin HCI, targeting the EU and US pha…
Product Launched

Wanbury Ltd Submits DMFs for Global API Launch; Patalganga Unit Receives Zero Observations

Wanbury Ltd expands global API reach with DMF submissions for Diphenhydramine HCl and Paroxetine HCl. Patalganga facility clears Korea MFDS audit wit…

Track Wanbury in real time

ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Wanbury files something material.

Start Free — 15-day trial
{# ── Promo popup — fires 5s after first page load per session. NEVER fires for visitors arriving from a search engine: a full-viewport overlay on a news article is an intrusive interstitial, and Google News policy is explicit that promotional material must not exceed the content. Direct, social and referral traffic still sees it. ─────────── #}